Sustained hypertension during Innovar and Innovar-N2O anesthesia.
D000328:Adult; D000758:Anesthesia; D000777:Anesthetics / Q000494:pharmacology; D001544:Benperidol / Q000009:adverse effects*; D002395:Catecholamines / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008012:Lidocaine; D008297:Male; D008875:Middle Aged; D009458:Neuroleptanalgesia; D009609:Nitrous Oxide / Q000009:adverse effects*; D009638:Norepinephrine / Q000378:metabolism
D000777:Anesthetics; D002395:Catecholamines; D001544:Benperidol; D008012:Lidocaine; D009609:Nitrous Oxide; D009638:Norepinephrine; D004837:Epinephrine